| Filed On | Filing |
|---|---|
| 15 Oct 2021 |
Form 4: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other · Theseus Pharmaceuticals, Inc.
Received 1,615,427 shares by conversion |
| 16 Feb 2017 |
Form 4: Schlesinger Sarah J., Director
Gave 15,600 shares as a gift · Returned 55,508 shares to the issuer · Disposed of 140,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Clackson Timothy P, President, R&D, CSO
Returned 220,444 shares to the issuer · Disposed of 234,125 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 87,530 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Haimovitz Jules, Director
Returned 18,008 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Bickerstaff George, Director
Returned 18,008 shares to the issuer · Disposed of 100,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Herron Jennifer Lyn, Exec V.P. Chief Comm'l Officer
Returned 450 shares to the issuer · Disposed of 300,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 5,291 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Cole Hugh M, SVP, Chief Business Officer
Returned 42,834 shares to the issuer · Disposed of 178,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 74,521 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Gansler Jayne M., Senior V.P. Human Resources
Disposed of 144,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 74,910 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Riedel Norbert G, Director
Returned 139,867 shares to the issuer · Disposed of 125,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Bollag Daniel M, Sr. VP, Reg. Affairs & Quality
Returned 126,352 shares to the issuer · Disposed of 146,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 56,105 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Panayiotopoulos Paris, Director
Returned 159,378 shares to the issuer · Disposed of 1,500,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 66,800 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Protopapas Anna, Director
Returned 41,910 shares to the issuer · Disposed of 125,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Soni Manmeet Singh, EVP, CFO & Treasurer
Returned 3,273 shares to the issuer · Disposed of 550,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 7,937 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Kogan Elona Esq., Sr. V. P. - General Counsel
Disposed of 200,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 106,085 Restricted Stock Units (Disposition to Issuer) |
| 16 Feb 2017 |
Form 4: Denner Alexander J, Director
Returned 12,903,173 shares to the issuer · Disposed of 150,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 8,800,000 3.625% Convertible Notes due 2019 (Disposition to Issuer) |
| 07 Feb 2017 |
Form 4: Cole Hugh M, SVP, Chief Business Officer
Received 19,167 shares by exercise or conversion · Gave up 6,249 shares to cover exercise price or tax ($54.3K) · Granted 9,788 Restricted Stock Units |
| 07 Feb 2017 |
Form 4: Kogan Elona Esq., Sr. V. P. - General Counsel
Granted 6,085 Restricted Stock Units |
| 07 Feb 2017 |
Form 4: Soni Manmeet Singh, EVP, CFO & Treasurer
Granted 7,937 Restricted Stock Units |
| 07 Feb 2017 |
Form 4: Bollag Daniel M, Sr. VP, Reg. Affairs & Quality
Granted 3,439 Restricted Stock Units |
| 07 Feb 2017 |
Form 4: Clackson Timothy P, President, R&D, CSO
Granted 14,550 Restricted Stock Units |
Loading...
